Latest Breaking News On - Roche venture fund - Page 15 : comparemela.com

NMD Pharma Raises €35 Million in a new Financing

NMD Pharma Raises €35 Million in a new Financing - New investor Jeito Capital joins current NMD Pharma investors - Proceeds will be used to progress lead.

Sabine dandiguianSabine dandiguiantoRoel bulthuisThomas holm pedersenLundbeck foundationRoche venture fundNovo holdingsConsilium strategic communicationsJeito capitalManaging partnerMyasthenia gravisHolm pedersenChief executive officerJane elliottAshley tappLindsey neville

Good Therapeutics lands $8M to develop protein drugs that work only where needed in the body

Good Therapeutics lands $8M to develop protein drugs that work only where needed in the body
geekwire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from geekwire.com Daily Mail and Mail on Sunday newspapers.

Diane hollenbaughJohn mulliganStanford universityRoche venture fundGood therapeuticsGood therapeutics photoCambrian genomicsNeela patelRivervest venture partnersDigitalis ventures

Freenome Raises $300M in Series D Financing to Advance Multiomics Platform for Early Cancer Detection

/PRNewswire/ Freenome, a privately held biotech company, today announced a Series D funding of $300 million. This brings the company s total financing to.

United statesRock springsSouth san franciscoMike nolanEllen hukkelhovenPeter kolchinskyKaiser permanenteBain capital life sciencesResearch companyLife sciences growth fundAmerican cancer society brightedge venturesEventide asset managementT rowe price associates incFreenome holdings incUnited states preventive services task forceRoche venture fund

Freenome Raises $300M in Series D Financing to Advance Multiomics Platform for Early Cancer Detection

Press release content from PR Newswire. The AP news staff was not involved in its creation.

United statesRock springsSouth san franciscoMike nolanEllen hukkelhovenPeter kolchinskyPrnewswire freenomeKaiser permanenteBain capital life sciencesResearch companyLife sciences growth fundAmerican cancer society brightedge venturesEventide asset managementT rowe price associates incFreenome holdings incUnited states preventive services task force

GlycoEra AG Raises CHF 45 Million (US$ 49 Million) Series A Financing to Develop Novel Biologics Based on Innovative Glycoengineering Platform

Financing round co-led by 5AM Ventures, Roche Venture Fund and Sofinnova Partners with participation from LimmaTech Biologics AG GlycoEra AG announced today the close of a CHF 45 million ($49 million)

United statesFrance generalSouth san franciscoCity ofUnited kingdomSan franciscoGraziano seghezziGraziano seghezzi sofinnovaVeronica gambillara fonckAmir faridmoayerGanesh kaundinyaKostenloser wertpapierhandelGlycoera customglycanMira chaurushiyaLaura mittmannMonique schiersing roche venture fund